Vancomycin Hydrochloride for Injection IP | Satdox-500

 

What is Satdox-500 – Vancomycin Hydrochloride for Injection IP

Satdox-500 is Vancomycin Hydrochloride for Injection IP, a glycopeptide antibiotic used to treat serious and life-threatening gram-positive bacterial infections. It is especially effective against resistant organisms such as MRSA (Methicillin-Resistant Staphylococcus aureus). Due to its strong antibacterial profile, it is widely used in hospitals and intensive care settings.

How Vancomycin Injection Works

Vancomycin works by inhibiting bacterial cell wall synthesis in gram-positive bacteria. It prevents the formation of the protective cell wall, leading to bacterial destruction. Unlike many other antibiotics, Vancomycin is particularly useful when infections do not respond to beta-lactam antibiotics.

Its targeted action makes it a critical option in the management of resistant infections.

Indications of Satdox-500 Injection

Satdox-500 is commonly prescribed for:

• Septicemia (bloodstream infections)
• Endocarditis
• Severe skin and soft tissue infections
• Bone and joint infections
• Hospital-acquired pneumonia
• MRSA infections

It is administered intravenously under strict medical supervision for optimal results.

Vancomycin Hydrochloride Injection Key Benefits

• Highly effective against resistant gram-positive bacteria
• Trusted therapy for MRSA infections
• Suitable for severe and hospital-acquired infections
• Reliable ICU-grade antibiotic

Dosage Information

Satdox-500 should be administered slowly via intravenous infusion as directed by a healthcare professional. Kidney function monitoring is important during therapy, as dosage adjustments may be required in renal impairment.

Patients should complete the prescribed treatment course to prevent antibiotic resistance and ensure effective recovery. Satdox-500 provides dependable and potent antibacterial coverage for serious infections requiring advanced care.